Final Fantasy 7 Remake Part 3 Nears Completion, Still on Unreal Engine 4
Square Enix’s Final Fantasy 7 Remake Part 3 is edging closer to final form, with development reportedly smooth and on schedule. During recent updates, key figures confirmed the script is complete, core builds are playable, and the team is pressing ahead toward delivery. Despite industry trends favoring newer technology, the studio remains committed to using Unreal Engine 4 for the final chapter.
Why This Matters Now
This update matters because Part 3 will tie off one of the industry’s most ambitious remake efforts. Fans have awaited this finale for years, and confirmation that the storyline is locked in and builds are functional offers hard reassurance. The continued use of Unreal Engine 4 signals a focus on stability over flashy upgrades, a sensible move at this late stage.
Script Complete, Development Advancing Steadily
Producers and directors have confirmed that the storyline for Part 3 wrapped up at the end of 2024, marking a major milestone. The team is now building and refining the game according to the planned schedule, with no reported delays. That suggests Square Enix remains on track for a release sometime around 2027 or 2028.
In a related comment, director Naoki Hamaguchi stated the project began immediately after Rebirth, around March or April 2024. At this point, the team is transitioning smoothly into full production.
Playable Builds Are Already Running
More concrete progress comes from playable builds now existing in-house. Hamaguchi shared that teams can actually interact with a functional version of the game, reinforcing that development is well underway—and not just notionally.
Unreal Engine 4 Chosen for Continuity and Efficiency
Contrary to the broader industry’s push toward Unreal Engine 5, Part 3 will remain on Unreal Engine 4. Hamaguchi cited the value of familiarity and prior custom tools built around UE4 as decisive factors. He emphasized that switching engines now would disrupt development and threaten momentum.
Multiplatform Strategy Shows No Sign of Slowing Down
Square Enix continues to pursue a broad multiplatform release. Part 3 is expected to launch on PlayStation, Xbox, PC, and Nintendo Switch 2. Separate platform teams and a dedicated “porting squad” are coordinating to ensure parity and avoid delays.
Hamaguchi also noted earlier difficulties with memory limitations on Xbox platforms. However, assuredly, the multiplatform approach isn’t derailing development.
Minigames and Nostalgia: Queen’s Blood and Snowboarding Return
The beloved Queen’s Blood card game is coming back—“powered up” with expanded mechanics. The original snowboarding minigame will also feature, now more tightly integrated into the main narrative. These elements hint at a richer, more immersive experience for players.
“The announcement timing has been decided,” Say Developers
Producer Tetsuya Nomura confirmed that the reveal schedule for Part 3 has already been set. Though details or a date haven’t been shared, this suggests fans can expect official news when Square Enix is ready.
What’s Coming Next for Fans
- Developers still must complete final polishing, optimization, and marketing preparation.
- Fans await an official title, trailer, and release window—possibly as early as late 2025 or sometime in 2026.
- Legacy features like Queen’s Blood and Airship exploration suggest the game aims to balance innovation with nostalgia.
“We’ve got builds running where you can actually experience what that theme is through the gameplay.”
— Naoki Hamaguchi
Final Thoughts
Final Fantasy 7 Remake Part 3 marks a pivotal moment for the remake trilogy. With the story now complete and playable builds in place, Square Enix is in the home stretch of development. The decision to stay on Unreal Engine 4 prioritizes solidity over experimental changes. Meanwhile, a multiplatform approach, nostalgia-driven game features, and a confirmed reveal schedule set the stage for a highly anticipated conclusion.
Fans should watch for the official reveal, forthcoming trailers, and a confirmed release window soon.
